AstraZeneca CEO Says Europe Prices Should Be Higher, U.S. Lower

814 views · Published 8 November 2018 · 2:41 · Indexed 10 November 2026

Channel: Bloomberg Television · 2018 · News & Politics

Watch on YouTube

Nov.08 -- AstraZeneca Plc Chief Executive Officer Pascal Soriot discusses drug pricing and Brexit preparations after the Cambridge, England-based company reported profit which beat analysts’ estimates. AstraZeneca's stock is the best performer among major European drugmakers since the start of the year. Soriot speaks with Bloomberg's Guy Johnson  on "Bloomberg Surveillance."

More from this channel